Cipta Sarana Medika Tbk. vs Tunas Alfin Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 163.22B, 2.44M 24h volume), while Tunas Alfin Tbk. trades at Rp785 (market cap 1.1T, 152.2K 24h volume). The key difference: Tunas Alfin Tbk. is far larger — about 6.7× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (2.44M versus 152.2K). Which is the better fit depends on your goals.
| DKHH | TALF | |
|---|---|---|
Market Cap | 163.22B | 1.1T |
Volume | 2.44M | 152.2K |
Lot | 24.43K | 1.52K |
Turnover | 155.81M | 125.02M |
Average Price | 63.78 | 821.4 |
Value | 155.81M | 125.02M |
Indicative Equilibrium Price | 64 | 870 |
Indicative Equilibrium Volume | 110.6K | 28 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Tunas Alfin Tbk (the Company) was founded in 1977 and is based in Jakarta, Indonesia. With one of the largest production capacities, and some of the most advanced equipment and technologies in the region, the Company has also grown into one of the leading integrated fine and Fast Moving Consumer Goods (FMCG) packaging companies in Asia.The Company is currently capable of undertaking several coating processes such as Silicone, Hot Melt, Extrusion, Pressure/Self-Adhesive, Wax Coating and Anti-fungus Coating.
Read more on TALF →